Ensysce Biosciences Inc.
13F holders, Q1 2024 (March 31)9holders
1famous investor
$0.79avg. 13F price*
At the end of Q1 2024, 9 institutions reported holding Ensysce Biosciences Inc. in their 13F filings. The largest holders were Sabby Management, LLC ($182K), Geode Capital Management, LLC ($14K) and Vanguard Group Inc. ($14K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Ensysce Biosciences Inc.
- CUSIP
- 293602405
- Latest filing quarter
- Q3 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $182K |
| Exits | 0 | $0 |
Ownership 9 holders
| Sabby Management, LLC | 1.31% | New | 230,554 | $182K |
| Geode Capital Management, LLC | 0.00% | Add +12.5% | 18,318 | $14K |
| Vanguard Group Inc. | 0.00% | No change | 18,175 | $14K |
| UBS Group AG | 0.00% | Add +420233.3% | 12,610 | $10K |
| Renaissance Technologies | 0.00% | Reduce -3.7% | 10,554 | $8K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +29.5% | 8,166 | $6K |
| BlackRock Inc. | 0.00% | No change | 975 | $770 |
| Main Street Group, LTD | 0.00% | New | 370 | $289 |
| Wells Fargo & Company | 0.00% | Add +4.2% | 25 | $20 |
"% of holder's portfolio" is ENSYSCE BIOSCIENCES INC's weight in each manager's 13F, not the share of Ensysce Biosciences Inc. the manager owns.